Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes.
Natural killer (NK) cells are large granular lymphocytes that participate in both innate and adaptive immune responses against tumors and pathogens. They are also involved in other conditions, including organ rejection, graft-versus-host disease, recurrent spontaneous abortions, and autoimmune disea...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3795664?pdf=render |
_version_ | 1811225203505627136 |
---|---|
author | Shyny Koshy Danli Wu Xueyou Hu Rajeev B Tajhya Redwan Huq Fatima S Khan Michael W Pennington Heike Wulff Patricia Yotnda Christine Beeton |
author_facet | Shyny Koshy Danli Wu Xueyou Hu Rajeev B Tajhya Redwan Huq Fatima S Khan Michael W Pennington Heike Wulff Patricia Yotnda Christine Beeton |
author_sort | Shyny Koshy |
collection | DOAJ |
description | Natural killer (NK) cells are large granular lymphocytes that participate in both innate and adaptive immune responses against tumors and pathogens. They are also involved in other conditions, including organ rejection, graft-versus-host disease, recurrent spontaneous abortions, and autoimmune diseases such as multiple sclerosis. We demonstrate that human NK cells express the potassium channels Kv1.3 and KCa3.1. Expression of these channels does not vary with expression levels of maturation markers but varies between adherent and non-adherent NK cell subpopulations. Upon activation by mitogens or tumor cells, adherent NK (A-NK) cells preferentially up-regulate KCa3.1 and non-adherent (NA-NK) cells preferentially up-regulate Kv1.3. Consistent with this different phenotype, A-NK and NA-NK do not display the same sensitivity to the selective KCa3.1 blockers TRAM-34 and NS6180 and to the selective Kv1.3 blockers ShK-186 and PAP-1 in functional assays. Kv1.3 block inhibits the proliferation and degranulation of NA-NK cells with minimal effects on A-NK cells. In contrast, blocking KCa3.1 increases the degranulation and cytotoxicity of A-NK cells, but not of NA-NK cells. TRAM-34, however, does not affect their ability to form conjugates with target tumor cells, to migrate, or to express chemokine receptors. TRAM-34 and NS6180 also increase the proliferation of both A-NK and NA-NK cells. This results in a TRAM-34-induced increased ability of A-NK cells to reduce in vivo tumor growth. Taken together, our results suggest that targeting KCa3.1 on NK cells with selective blockers may be beneficial in cancer immunotherapy. |
first_indexed | 2024-04-12T09:02:49Z |
format | Article |
id | doaj.art-9d49b71d5a4e498ba0b089b1c075835f |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-04-12T09:02:49Z |
publishDate | 2013-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-9d49b71d5a4e498ba0b089b1c075835f2022-12-22T03:39:11ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01810e7674010.1371/journal.pone.0076740Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes.Shyny KoshyDanli WuXueyou HuRajeev B TajhyaRedwan HuqFatima S KhanMichael W PenningtonHeike WulffPatricia YotndaChristine BeetonNatural killer (NK) cells are large granular lymphocytes that participate in both innate and adaptive immune responses against tumors and pathogens. They are also involved in other conditions, including organ rejection, graft-versus-host disease, recurrent spontaneous abortions, and autoimmune diseases such as multiple sclerosis. We demonstrate that human NK cells express the potassium channels Kv1.3 and KCa3.1. Expression of these channels does not vary with expression levels of maturation markers but varies between adherent and non-adherent NK cell subpopulations. Upon activation by mitogens or tumor cells, adherent NK (A-NK) cells preferentially up-regulate KCa3.1 and non-adherent (NA-NK) cells preferentially up-regulate Kv1.3. Consistent with this different phenotype, A-NK and NA-NK do not display the same sensitivity to the selective KCa3.1 blockers TRAM-34 and NS6180 and to the selective Kv1.3 blockers ShK-186 and PAP-1 in functional assays. Kv1.3 block inhibits the proliferation and degranulation of NA-NK cells with minimal effects on A-NK cells. In contrast, blocking KCa3.1 increases the degranulation and cytotoxicity of A-NK cells, but not of NA-NK cells. TRAM-34, however, does not affect their ability to form conjugates with target tumor cells, to migrate, or to express chemokine receptors. TRAM-34 and NS6180 also increase the proliferation of both A-NK and NA-NK cells. This results in a TRAM-34-induced increased ability of A-NK cells to reduce in vivo tumor growth. Taken together, our results suggest that targeting KCa3.1 on NK cells with selective blockers may be beneficial in cancer immunotherapy.http://europepmc.org/articles/PMC3795664?pdf=render |
spellingShingle | Shyny Koshy Danli Wu Xueyou Hu Rajeev B Tajhya Redwan Huq Fatima S Khan Michael W Pennington Heike Wulff Patricia Yotnda Christine Beeton Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes. PLoS ONE |
title | Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes. |
title_full | Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes. |
title_fullStr | Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes. |
title_full_unstemmed | Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes. |
title_short | Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes. |
title_sort | blocking kca3 1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes |
url | http://europepmc.org/articles/PMC3795664?pdf=render |
work_keys_str_mv | AT shynykoshy blockingkca31channelsincreasestumorcellkillingbyasubpopulationofhumannaturalkillerlymphocytes AT danliwu blockingkca31channelsincreasestumorcellkillingbyasubpopulationofhumannaturalkillerlymphocytes AT xueyouhu blockingkca31channelsincreasestumorcellkillingbyasubpopulationofhumannaturalkillerlymphocytes AT rajeevbtajhya blockingkca31channelsincreasestumorcellkillingbyasubpopulationofhumannaturalkillerlymphocytes AT redwanhuq blockingkca31channelsincreasestumorcellkillingbyasubpopulationofhumannaturalkillerlymphocytes AT fatimaskhan blockingkca31channelsincreasestumorcellkillingbyasubpopulationofhumannaturalkillerlymphocytes AT michaelwpennington blockingkca31channelsincreasestumorcellkillingbyasubpopulationofhumannaturalkillerlymphocytes AT heikewulff blockingkca31channelsincreasestumorcellkillingbyasubpopulationofhumannaturalkillerlymphocytes AT patriciayotnda blockingkca31channelsincreasestumorcellkillingbyasubpopulationofhumannaturalkillerlymphocytes AT christinebeeton blockingkca31channelsincreasestumorcellkillingbyasubpopulationofhumannaturalkillerlymphocytes |